Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…
According to Dealroom’s European Spinout Report 2025, 76 European deep tech and life sciences spinouts have either reached $1 billion valuations, $100 million in revenue, or both.
After a tumultuous year, venture investors are still optimistic about climate tech’s long term prospects, especially as data centers continue to drive demand for electricity, manufacturing, and materials.
The coffee giant is shuttering roughly 400 locations nationwide, concentrated in major cities, as part of CEO Brian Niccol’s $1 billion restructuring plan.